Prostatis Group’s Chevron CVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Sell
3,426
-703
-17% -$128K 0.18% 89
2025
Q4
$629K Buy
4,129
+1,017
+33% +$155K 0.15% 92
2025
Q3
$483K Sell
3,112
-164
-5% -$25.4K 0.12% 98
2025
Q2
$469K Sell
3,276
-387
-11% -$54.6K 0.13% 99
2025
Q1
$613K Sell
3,663
-133
-4% -$20.8K 0.19% 86
2024
Q4
$550K Sell
3,796
-330
-8% -$50.5K 0.16% 102
2024
Q3
$608K Sell
4,126
-6,846
-62% -$1.02M 0.2% 83
2024
Q2
$1.73M Sell
10,972
-66
-0.6% -$10.5K 0.61% 47
2024
Q1
$1.73M Buy
11,038
+1,437
+15% +$217K 0.66% 45
2023
Q4
$1.43M Buy
9,601
+26
+0.3% +$3.93K 0.6% 44
2023
Q3
$1.63M Sell
9,575
-939,886
-99% -$152M 0.8% 30
2023
Q2
$1.15M Buy
949,461
+941,727
+12,176% +$151M 0.53% 44
2023
Q1
$1.26M Sell
7,734
-168
-2% -$28.2K 0.66% 37
2022
Q4
$1.42M Buy
+7,902
New +$1.38M 0.87% 31
2022
Q2
Sell
-6,500
Closed -$1.06M 53
2022
Q1
$1.06M Buy
+6,500
New +$932K 0.85% 34

Other funds holding CVX

Prostatis Group's CVX Position: Q1 2026 in Review

Prostatis Group reduced its Chevron (CVX) stake by 17% in Q1 2026, selling an estimated $128K and leaving 3,426 shares worth $709K. The position accounts for 0.18% of the portfolio, ranked #89.

Prostatis Group first reported a position in CVX in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.73M in Q1 2024. 4,274 funds tracked by Wall St. Rank hold CVX as of Q1 2026.

  • Prostatis Group held 3,426 shares of Chevron worth $709K as of Q1 2026.
  • Prostatis Group sold 703 Chevron shares in Q1 2026, an estimated $128K.
  • Chevron made up 0.18% of Prostatis Group's portfolio in Q1 2026, its #89 holding.
  • Prostatis Group first reported a position in Chevron in Q1 2022 and has held it in 15 quarters since.
  • Prostatis Group's Chevron position peaked at $1.73M in Q1 2024.
  • 4,274 funds tracked by Wall St. Rank held Chevron as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.